Nils Aage Brünner
Chief Executive Officer presso Timpco ApS
Provenienza dei contatti di primo grado di Nils Aage Brünner
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Copenhagen
214
| College/University | Other Consumer Services | 214 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.
11
| Private Company | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 9 | |
Gibson Oncology LLC
 Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL.
5
| Private Company | Biotechnology | 5 |
CytoTrack ApS
 CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark.
5
| Private Company | Electronic Equipment/Instruments | 5 |
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer.
4
| Non-Profit Organization | Miscellaneous Commercial Services | 4 |
Danish National Research Foundation
3
| Private Company | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nils Aage Brünner tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VESTAS WIND SYSTEMS A/S | Electrical Products | Director/Board Member Director/Board Member | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Director/Board Member | |
| COLOPLAST A/S | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer Sales & Marketing | |
| CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Founder Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| AMBU A/S | Medical Specialties | Chairman Director/Board Member | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
| University of California, Los Angeles | College/University | Masters Business Admin Graduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
| University of Aarhus | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Chief Executive Officer Chairman | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Founder Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aalborg | College/University | Director/Board Member Undergraduate Degree | |
| SOLAR A/S | Engineering & Construction | Director/Board Member Chairman | |
| The Danish Academy of Technical Sciences | College/University | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Founder | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Founder Founder | |
DELTA A/S (Denmark)
 DELTA A/S (Denmark) Miscellaneous Commercial ServicesCommercial Services DELTA A/S is a testing and consulting private company based in Hørsholm, Denmark. DELTA A/S operates as a testing and consulting Danish company. The CEO of the company is Per Hartlev. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| VIROGATES A/S | Medical Specialties | Director/Board Member Founder | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Director of Finance/CFO Corporate Officer/Principal | |
| IT-Væksthus A/S | Director/Board Member Chairman | ||
DHI Group A/S
 DHI Group A/S Packaged SoftwareTechnology Services DHI Group A/S is a Danish company that provides solutions to water challenges. The private company is based in Denmark, specifically in Hørsholm, and has subsidiaries in Singapore, the United States, Australia, and Czechia. The company's expertise includes saving water, sharing it fairly, improving its quality, quantifying its impact, and managing its flow. The company offers access to real-time data and emerging technologies to unlock solutions to water challenges. | Packaged Software | Chairman Chairman | |
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Steno Diabetes Center A/S | Chairman Corporate Officer/Principal | ||
| Copenhagen University Hospital | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S (CIP) is a private equity firm founded- in 2012 by Jakob Baruël Poulsen, Christian Skakkebæk, Torsten Lodberg Smed, and Rune Bro Róin. The firm is headquartered in Copenhagen, Denmark. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| Danish Parliament | Corporate Officer/Principal Corporate Officer/Principal | ||
| CURASIGHT A/S | Medical Specialties | Corporate Officer/Principal Founder | |
| 2CUREX AB | Medical Specialties | Director/Board Member Founder Founder Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Director/Board Member Founder | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Symbion Fonden | Director/Board Member Director/Board Member | ||
The European Council on Foreign Relations (United Kingdom)
 The European Council on Foreign Relations (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The European Council on Foreign Relations (ECFR) is a UK-based think-tank founded in 2007 by Mark Leonard. The British company conducts independent research on European foreign and security policy, with a focus on analyzing the geopolitics of the relationship between the European Union and other countries. ECFR's Africa Programme specifically examines foreign policy tools and strategies related to the continent. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Cobis A/S
 Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services. | Miscellaneous Commercial Services | Director/Board Member Chairman |
Statistiche
Distribuzione geografica
| Danimarca | 46 |
| Svezia | 4 |
| Stati Uniti | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 17 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Miscellaneous | 4 |
| Finance | 4 |
Posizioni
| Director/Board Member | 414 |
| Corporate Officer/Principal | 189 |
| Chairman | 143 |
| Founder | 87 |
| Chief Executive Officer | 77 |
Contatti più connessi
| Insiders | |
|---|---|
| Jørgen Vilhelm Bardenfleth | 64 |
| Arne Gerlyng-Hansen | 46 |
| Agnete Raaschou-Nielsen | 32 |
| Peter Buhl Jensen | 32 |
| Anders Hove | 31 |
| Peter Andersen | 26 |
| Jørgen Drejer | 26 |
| Lars Åke Alvar Lidgren | 24 |
| Thomas Dyrberg | 24 |
| Lars Rebien Sørensen | 22 |
| Helle Thorning-Schmidt | 21 |
| Lars Søren Rasmussen | 21 |
| Thomas Feldthus | 20 |
| Lykke Friis | 19 |
| Povl-André Bang Bendz | 19 |
- Borsa valori
- Insiders
- Nils Aage Brünner
- Connessioni Società
